Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.
Press releases published on May 29, 2025
Annexon Biosciences to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
BRISBANE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory …
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences
GlobeNewswire
·
May 29, 2025
FOSTER CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, …
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
GlobeNewswire
·
May 29, 2025
SAN FRANCISCO, May 29, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic diseases, today announced that management will …
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025
GlobeNewswire
·
May 29, 2025
– 14 abstracts accepted, including four oral presentations – – Interim analysis of real-world REFRESH study demonstrated clinically significant efficacy and improvement of EDS for patients who switched from twice-nightly oxybate to once-at-bedtime LUMRYZ – …
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
GlobeNewswire
·
May 29, 2025
LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that management will present at the following investor conferences in June: Jefferies 2025 Global Healthcare Conference on Thursday, June 5 …
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
GlobeNewswire
·
May 29, 2025
CAMBRIDGE, Mass., May 29, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration (FDA) …
Gyre Therapeutics Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
GlobeNewswire
·
May 29, 2025
SAN DIEGO, May 29, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, today …
Cytokinetics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
SOUTH SAN FRANCISCO, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that members of the Company’s management team are scheduled to participate in a fireside chat at the Jefferies Global Healthcare …
Arcutis to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
GlobeNewswire
·
May 29, 2025
WESTLAKE VILLAGE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Theratechnologies Reports on its Annual Meeting of Shareholders
GlobeNewswire
·
May 29, 2025
MONTREAL, May 29, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, reported the voting results from its annual meeting of shareholders held today …
Theratechnologies rend compte de son assemblée annuelle des actionnaires
GlobeNewswire
·
May 29, 2025
MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- Theratechnologies inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique au stade commercial, a rapporté les résultats du vote lors de son assemblée annuelle des …
Time to act on Indigenous health inequities: ending discrimination based on place of residence!
GlobeNewswire
·
May 29, 2025
National Forum on Urban Indigenous Health Governance in Care, Health Services and Healing MONTRÉAL, May 29, 2025 (GLOBE NEWSWIRE) -- During the National Forum on Urban Indigenous Health Governance in Care, Health Services and Healing, the Native Friendship …
Iniquité en santé autochtone : il faut mettre fin à la discrimination basée sur le lieu de résidence.
GlobeNewswire
·
May 29, 2025
Forum national sur la gouvernance urbaine en santé autochtone en matière de soins, de services de santé et de guérison MONTRÉAL, 29 mai 2025 (GLOBE NEWSWIRE) -- À l’occasion du Forum national sur la gouvernance urbaine en santé autochtone en matière de …
Bispecific Antibody Drug Conjugates Clinical Trials Bispecific ADC Market Size Insight
GlobeNewswire
·
May 29, 2025
Delhi, May 29, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report: Report Answers Question On Why There Exist Need For Bispecific Antibody Drug …
NeuroOne to Attend MedInvest’s MedTech, AI & Digital Health Conference on June 3-4, 2025
GlobeNewswire
·
May 29, 2025
EDEN PRAIRIE, Minn., May 29, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from …
Krabbe Disease Market Poised for Growth During the Forecast Period (2025–2034) with Advancements in Gene Therapy and Treatment Options | DelveInsight
GlobeNewswire
·
May 29, 2025
New York, USA, May 29, 2025 (GLOBE NEWSWIRE) -- Krabbe Disease Market Poised for Growth During the Forecast Period (2025–2034) with Advancements in Gene Therapy and Treatment Options | DelveInsight The dynamics of the Krabbe disease market are expected to …
Global Smart Inhalers Market to Observe Impressive Growth at a CAGR of ~21% by 2032 | DelveInsight
GlobeNewswire
·
May 29, 2025
New York, USA, May 29, 2025 (GLOBE NEWSWIRE) -- Global Smart Inhalers Market to Observe Impressive Growth at a CAGR of ~21% by 2032 | DelveInsight The smart inhalers market is experiencing significant growth, driven by the increasing incidence of …
VERAXA Biotech to Attend Key Industry Conferences to Showcase BiTAC Technology Platform
GlobeNewswire
·
May 29, 2025
ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp. (NASDAQ:VACH, “Voyager”), announced today it will be attending …
HealthPRO Canada and Hospice Palliative Care Ontario Partner to Strengthen Procurement for Ontario Hospices
GlobeNewswire
·
May 29, 2025
Oakville, ON, May 29, 2025 (GLOBE NEWSWIRE) -- HealthPRO Canada, the country’s national group contracting provider for healthcare, is proud to announce a new strategic partnership with Hospice Palliative Care Ontario (HPCO). This collaboration aims to help …
Basel Medical Group Ltd Reaffirms Strong Financial Position Amid Market Volatility
GlobeNewswire
·
May 29, 2025
Singapore, May 29, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL or the “Company”), today reaffirmed the strength of its underlying financial performance and strategic outlook, despite recent volatility in its share price. Speaking on …